Sodium-glucose cotransporter inhibitors may reduce the risk of pneumonia: an updated meta-analysis of cardiovascular outcome trials

The present meta-analysis included 8 cardiovascular outcome trials with 57,185 patients at high cardiometabolic risk. In comparison with placebo, treatment with sodium-glucose cotransporter inhibitors was associated with a significantly lower risk of pneumonia (RR 0.85, 95% CI 0.76–0.95, p = 0.004;...

Descripción completa

Detalles Bibliográficos
Autores principales: Barkas, Fotios, Anastasiou, Georgia, Milionis, Haralampos, Liberopoulos, Evangelos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179959/
https://www.ncbi.nlm.nih.gov/pubmed/34123693
http://dx.doi.org/10.1007/s13340-021-00515-4
_version_ 1783703899355480064
author Barkas, Fotios
Anastasiou, Georgia
Milionis, Haralampos
Liberopoulos, Evangelos
author_facet Barkas, Fotios
Anastasiou, Georgia
Milionis, Haralampos
Liberopoulos, Evangelos
author_sort Barkas, Fotios
collection PubMed
description The present meta-analysis included 8 cardiovascular outcome trials with 57,185 patients at high cardiometabolic risk. In comparison with placebo, treatment with sodium-glucose cotransporter inhibitors was associated with a significantly lower risk of pneumonia (RR 0.85, 95% CI 0.76–0.95, p = 0.004; I(2) = 0, p = 0.48). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13340-021-00515-4.
format Online
Article
Text
id pubmed-8179959
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Singapore
record_format MEDLINE/PubMed
spelling pubmed-81799592021-06-07 Sodium-glucose cotransporter inhibitors may reduce the risk of pneumonia: an updated meta-analysis of cardiovascular outcome trials Barkas, Fotios Anastasiou, Georgia Milionis, Haralampos Liberopoulos, Evangelos Diabetol Int Short Communication The present meta-analysis included 8 cardiovascular outcome trials with 57,185 patients at high cardiometabolic risk. In comparison with placebo, treatment with sodium-glucose cotransporter inhibitors was associated with a significantly lower risk of pneumonia (RR 0.85, 95% CI 0.76–0.95, p = 0.004; I(2) = 0, p = 0.48). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13340-021-00515-4. Springer Singapore 2021-06-06 /pmc/articles/PMC8179959/ /pubmed/34123693 http://dx.doi.org/10.1007/s13340-021-00515-4 Text en © The Japan Diabetes Society 2021
spellingShingle Short Communication
Barkas, Fotios
Anastasiou, Georgia
Milionis, Haralampos
Liberopoulos, Evangelos
Sodium-glucose cotransporter inhibitors may reduce the risk of pneumonia: an updated meta-analysis of cardiovascular outcome trials
title Sodium-glucose cotransporter inhibitors may reduce the risk of pneumonia: an updated meta-analysis of cardiovascular outcome trials
title_full Sodium-glucose cotransporter inhibitors may reduce the risk of pneumonia: an updated meta-analysis of cardiovascular outcome trials
title_fullStr Sodium-glucose cotransporter inhibitors may reduce the risk of pneumonia: an updated meta-analysis of cardiovascular outcome trials
title_full_unstemmed Sodium-glucose cotransporter inhibitors may reduce the risk of pneumonia: an updated meta-analysis of cardiovascular outcome trials
title_short Sodium-glucose cotransporter inhibitors may reduce the risk of pneumonia: an updated meta-analysis of cardiovascular outcome trials
title_sort sodium-glucose cotransporter inhibitors may reduce the risk of pneumonia: an updated meta-analysis of cardiovascular outcome trials
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179959/
https://www.ncbi.nlm.nih.gov/pubmed/34123693
http://dx.doi.org/10.1007/s13340-021-00515-4
work_keys_str_mv AT barkasfotios sodiumglucosecotransporterinhibitorsmayreducetheriskofpneumoniaanupdatedmetaanalysisofcardiovascularoutcometrials
AT anastasiougeorgia sodiumglucosecotransporterinhibitorsmayreducetheriskofpneumoniaanupdatedmetaanalysisofcardiovascularoutcometrials
AT milionisharalampos sodiumglucosecotransporterinhibitorsmayreducetheriskofpneumoniaanupdatedmetaanalysisofcardiovascularoutcometrials
AT liberopoulosevangelos sodiumglucosecotransporterinhibitorsmayreducetheriskofpneumoniaanupdatedmetaanalysisofcardiovascularoutcometrials

Ejemplares similares